Annual report outlining national-level achievements and operational performance in malaria and NTD control during FY 2020/2021. Documents Indoor Residual Spraying (IRS) across 13 high-burden districts achieving >99% coverage using organophosphate insecticides, distribution of 1.5 million LLINs through antenatal care and immunization platforms, and Mass Drug Administration campaigns for deworming in endemic districts.
The report includes entomological surveillance conducted through sentinel sites with vector density monitoring, insecticide resistance testing, and parasitological trends. Integration of interventions with routine surveillance via DHIS2 and field-level verification mechanisms. Focus on sustaining programmatic resilience amidst COVID-19 disruptions and aligning with global SDG 3.3 targets.
Provides critical insights for health system planning, malaria program evaluation, and submission to global partners such as WHO, PMI, and the Global Fund.
